Navigation Links
MO BIO Laboratories, Inc. Launches PowerWater(R) RNA Isolation Kit
Date:9/23/2009

CARLSBAD, Calif., Sept. 23 /PRNewswire/ -- MO BIO Laboratories, Inc., the leader in soil, water and microbial nucleic acid purification, announces the launch of an innovative new product, PowerWater(R) RNA Isolation Kit, designed to isolate high-quality total RNA from a variety of filtered water samples. PowerWater(R) RNA Isolation Kit is expected to be a valuable tool in the developing fields of water safety testing, microbial community analysis and metagenomics.

The PowerWater(R) RNA Isolation Kit is the first kit exclusively designed to isolate RNA from microbes present in environmental water samples including bacteria (both gram + and gram -), fungi and algae. This kit includes our novel PowerWater(R) bead tubes for optimal lysis, our patented Inhibitor Removal Technology(R) (IRT) for better sensitivity in RT-PCR, and it yields RNA of high quality and purity. With IRT, even water containing heavy amounts of contaminants can be processed to provide inhibitor-free RNA. The kit can isolate RNA from common filter membrane types with a protocol that is fast and simple taking less than 40 minutes.

The PowerWater(R) RNA Isolation Kit is available now. For more information visit the MO BIO website (www.mobio.com) or call 800-606-6246 to order.

MO BIO Laboratories, Inc. (www.mobio.com) has developed innovative tools for researchers in Molecular Biology since 1993. A global leader in solutions for soil and microbial nucleic acid purification, MO BIO's Power(R) kits contain patented Inhibitor Removal Technology(R) for removal of PCR inhibiting substances during the nucleic acid purification procedure. For samples that do not require inhibitor removal, MO BIO's UltraClean(R) line includes optimized products for DNA and RNA isolation from a variety of sample types. Also for clinical samples, the BiOstic(TM) kits provide solutions for higher yields and purity of nucleic acids. At MO BIO Laboratories, Inc., our focus is quality products that work, save time and function for all sample types, not just the easy ones. It is MO BIO's aim to make researchers' working lives more productive and efficient, creating time to focus on what is critical, not just in work, but in life.


'/>"/>
SOURCE MO BIO Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. DermTech and Stiefel Laboratories, Inc. to Further Evaluate EGIR(TM) Technology
2. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets
3. Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
4. Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108
5. Roxane Laboratories, Inc. Announces the Launch of Mycophenolate Mofetil 250mg Capsules and 500mg Tablets
6. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
7. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009
8. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
9. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings
10. Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger
11. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company ... National Institute of Mental Health (NIMH) for the further advancement of the company’s 3-month ... technology and is expected to deliver therapeutic levels of olanzapine for a period of ...
(Date:2/24/2017)... , Feb. 24, 2017  Aethlon Medical, Inc. (Nasdaq: ... authored by its Chairman and CEO, Jim Joyce ... Munich Security Conference last Saturday, Bill Gates ... kill more people than nuclear weapons. Mr. Gates expressed ... U.K. intelligence agencies, that scientific terrorists have access to ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... (NASDAQ: VWR), the leading global independent provider of product and ... financial results for the fourth quarter and full year ended ... 4Q16 record quarterly net sales of $1.13 billion, up 1.6% ... 4Q16 EMEA-APAC segment net sales increased 0.4%, ... sales increased 2.5%, or down 0.9% on an organic basis, ...
Breaking Biology Technology:
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
Breaking Biology News(10 mins):